Please Wait...

Randomization & Trial Supply Management

Bioclinica offers the industry's only purpose-built, end-to-end, configurable randomization and trial supply management software platform. The flexible, intelligent RTSM platform combines the latest release of Bioclinica's IRT and advanced supply optimization and forecasting software to significantly cut time, effort and cost for even the most complex global trials.

Bioclinica Agile RTSM

Run and compare different supply scenarios against trial objectives (e.g. schedule, cost, feasibility) for the optimum supply strategy

Accurately assess drug demand at study and program level; provide finished goods to API

Build, implement, test and deploy protocols in as little as two weeks with an integrated supply strategy

Accomplish fast, accurate patient randomization aligned with protocol

Get the right drugs to the right sites and patients at the right time with integrated, optimized RTSM

Identify and adjust enrollment and supply needs based on actuals

Reduce waste and destruction and reconciliation time, effort and cost with continually updated supply plans

Achieve faster database lock, lower cost and effort, yet higher quality data with continual optimization

See Bioclinica’s agile approach to IRT development…

With Bioclinica’s Agile RTSM platform, our customers are building, implementing, testing and deploying new protocols in as little as two weeks, reducing drug waste and study costs by millions of dollars and identifying changing trial conditions months in advance, lowering the risk to patients and studies.

THE AGILE APPROACH TO BIOCLINICA'S TRIDENT IRT

TRIDENT IRT

The leading end-to-end product and technology solution for sponsors and CROs.
LEARN MORE

OPTIMIZER

Powerful forecasting and demand-planning technology to manage global logistics of the clinical supply chain.
LEARN MORE

 


 

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Handy guide for the pharmacovigilance folks! https://t.co/tOyQWkiNhW
bioclinica (Yesterday)
#ClinicalResearch sites, REJOICE @bioclinica SMART Submit 4 cloud rsch image mgmt /subm is here! @OutsourcPharmahttp://ow.ly/odCh30grhnY
bioclinica (Yesterday)
What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (2 days ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (3 days ago)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (3 days ago)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices